1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TRAPPC11 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA SCIMP CTRPv2 pan-cancer AAC 0.11 0.001
mRNA C2orf42 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA WDR5 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA SVIL CTRPv2 pan-cancer AAC -0.11 0.001
mRNA ESR1 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA TRADD CTRPv2 pan-cancer AAC -0.11 0.001
mRNA TRIP4 CTRPv2 pan-cancer AAC -0.1 0.001
mRNA ZBTB3 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA RIN1 CTRPv2 pan-cancer AAC -0.11 0.001
Download CSV